Edgewise Therapeutics, Inc. (EWTX)
45.24
+0.52
(+1.16%)
USD |
NASDAQ |
Aug 25, 13:50
Edgewise Therapeutics Market Cap : 4.876B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.820B |
| August 21, 2026 | 4.762B |
| August 20, 2026 | 4.666B |
| August 19, 2026 | 5.005B |
| August 18, 2026 | 4.754B |
| August 17, 2026 | 4.746B |
| August 14, 2026 | 4.760B |
| August 13, 2026 | 4.654B |
| August 12, 2026 | 4.695B |
| August 11, 2026 | 4.776B |
| August 10, 2026 | 4.805B |
| August 07, 2026 | 4.690B |
| August 06, 2026 | 4.787B |
| August 05, 2026 | 4.849B |
| August 04, 2026 | 4.818B |
| August 03, 2026 | 4.125B |
| July 31, 2026 | 4.131B |
| July 30, 2026 | 4.420B |
| July 29, 2026 | 4.272B |
| July 28, 2026 | 4.337B |
| July 27, 2026 | 4.471B |
| July 24, 2026 | 4.390B |
| July 23, 2026 | 4.223B |
| July 22, 2026 | 4.120B |
| July 21, 2026 | 4.254B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.171B |
| July 17, 2026 | 4.273B |
| July 16, 2026 | 4.105B |
| July 15, 2026 | 4.388B |
| July 14, 2026 | 4.270B |
| July 13, 2026 | 4.436B |
| July 10, 2026 | 4.881B |
| July 09, 2026 | 5.197B |
| July 08, 2026 | 4.976B |
| July 07, 2026 | 4.636B |
| July 06, 2026 | 4.310B |
| July 02, 2026 | 4.252B |
| July 01, 2026 | 4.208B |
| June 30, 2026 | 4.367B |
| June 29, 2026 | 4.398B |
| June 26, 2026 | 4.456B |
| June 25, 2026 | 4.481B |
| June 24, 2026 | 4.546B |
| June 23, 2026 | 4.174B |
| June 22, 2026 | 3.923B |
| June 18, 2026 | 3.956B |
| June 17, 2026 | 3.743B |
| June 16, 2026 | 3.649B |
| June 15, 2026 | 3.784B |
| June 12, 2026 | 3.744B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 16.00M |
| CNBX Pharmaceuticals, Inc. | 0.2214M |
| GB Sciences, Inc. | 0.1221M |
| Arvinas, Inc. | 628.19M |
| Fulcrum Therapeutics, Inc. | 293.70M |
Market Cap Related Metrics
| PEG Ratio | -1.296 |
| Price to Book Value | 10.88 |
| Price | 45.24 |
| Earnings Yield | -4.09% |
| PEGY Ratio | -1.296 |